What is the Charles River Laboratories Intl. Inc (CRL) price today?

The price of Charles River Laboratories Intl. Inc (CRL) today is $170. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/CRL

Buy & Sell Charles River Laboratories Intl. Inc (CRL) – Charles River Laboratories Intl. Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

Charles River Laboratories (CRL) trades at $169.80, up 1.23% on the day, with a bearish technical signal but strong analyst consensus. The company has beaten earnings estimates for three consecutive quarters, though recent annual profitability has declined sharply. Recent news highlights strategic divestitures of underperforming assets and participation in key healthcare conferences. The stock currently trades near its pivot point of $170, with immediate support at $167 and resistance at $172.

The outlook is mixed: robust analyst buy ratings (68.6%) and a $192.50 price target suggest upside, but high P/E (684.85), negative net margins, and bearish technicals pose risks. Investment opportunity hinges on successful execution of strategic asset sales and a return to historical profitability levels, while risks include sustained margin pressure and high valuation multiples.

Read full analysis

Key Stats

Market Cap
$8.38B
Sector
Health
3M Drawdown
-28.73%
Enterprise Value
$10.73B
Dividend Yield
-
Typical Hold Time
32 days

$170

52W Low: $115.08

28 Apr 2025

52W High: $226.77

21 Jan 2026

Charles River Laboratories Intl. Inc (CRL) is currently valued at a market capitalization of $8.38B, with an enterprise value of $10.73B. Over the past 52 weeks, Charles River Laboratories Intl. Inc has traded between a low of $115.08 and a high of $226.77, highlighting its annual price range. Over the past three months, Charles River Laboratories Intl. Inc has recorded a drawdown of -28.73%, reflecting recent price volatility. On average, investors hold Charles River Laboratories Intl. Inc for approximately 32 days, indicating typical investor behavior on the platform.

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Technical Indicators

Overall Summary

Bearish (10)Neutral (7)Bullish (10)

News

Globe Newswire5 mon ago

Lead Optimization Services in Drug Discovery Market to Reach USD 10.26 Billion by 2034, Driven by Rising R&D Activity

Globe Newswire5 mon ago

Innovative Drug CRO Market to Soar USD 96.06 Billion by 2035, Expanding at 5.44% CAGR

Benzinga6 mon ago

Charles River Beat Expectations But Why Is The Stock Falling?

Globe Newswire6 mon ago

Cell-based Assays Market Size to Reach USD 35.34 Billion by 2032, Driven by Demand for Drug Discovery and Advanced Biotechnology Research – SNS Insider

Globe Newswire6 mon ago

Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$8.38B
Sector
Health
3M Drawdown
-28.73%
Enterprise Value
$10.73B
Dividend Yield
-
Typical Hold Time
32 days

$170

52W Low: $115.08

28 Apr 2025

52W High: $226.77

21 Jan 2026

Let’s invest in this asset by signing up or download!

Buy & Sell Charles River Laboratories Intl. Inc (CRL) – Charles River Laboratories Intl. Inc Price Today

Aura AI Summary

Key Stats

About Charles River Laboratories Intl. Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store